⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL517339 | 1.00 | — | — | |
| SCHEMBL517340 | 1.00 | — | — | |
| SCHEMBL517338 | 1.00 | — | — | |
| SCHEMBL1525454 | 0.97 | ALOX15 (0.74) | — | |
| SCHEMBL29394097 | 0.97 | ALOX15 (0.74) | — | |
| SCHEMBL1374556 | 0.97 | ALOX15 (0.74) | — | |
| SCHEMBL8089487 | 0.97 | ALOX15 (0.74) | — | |
| Diethylamine SCHEMBL1524932 | 0.88 | ALOX15 (1.00) | — | |
| Diethylamine SCHEMBL1524933 | 0.88 | ALOX15 (1.00) | — | |
| Diethylamine SCHEMBL447262 | 0.88 | ALOX15 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6306841-B1 | NITROVASODILATOR SELECTED FROM SODIUM NITROPRUSSIDE, DIAZENIUM DIOLATE MOLSIDOMINE, LINSIDOMINE CHLORHYDRATE, S-NITROSOTHIOLS, ORGANIC NITRATES, PHARMACOLOGICALLY ACCEPTABLE SALTS, | ASIVI, LLC | 2001-10-23 | — | — | US | claimed |
| US-6266560-B1 | Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction | GENETRONICS, INC. | 2001-07-24 | — | — | US | claimed |
| WO-1999065563-A1 | ELECTRICALLY ASSISTED TRANSDERMAL METHOD AND APPARATUS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | GENETRONICS, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| US-20240158359-A1 | HYDROLYSIS-RESISTANT ESTERS FOR DRUG AND IMAGING AGENT DELIVERY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-05-16 | — | — | US | disclosed |
| WO-2024095177-A1 | MANGANESE BIFUNCTIONAL CHELATING AGENT CONJUGATION PLATFORM FOR TARGETED MR IMAGING | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-05-10 | — | — | WO | disclosed |
| US-20230285399-A1 | Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin | KATAIRO GMBH (DE) | 2023-09-14 | — | — | US | disclosed |
| EP-4192445-A1 | COMPOUND FOR THE TREATMENT AND PROPHYLAXIS OF A LIPOFUSCIN-ASSOCIATED DISEASE AND/OR A DISEASE ASSOCIATED WITH AGED OXIDIZED MELANIN | Schraermeyer, Ulrich (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-20230080520-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2023-03-16 | — | — | US | disclosed |
| EP-3949958-A1 | COMPOUND FOR THE TREATMENT AND PROPHYLAXIS OF A LIPOFUSCIN-ASSOCIATED DISEASE | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20210205415-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC | 2021-07-08 | — | — | US | disclosed |
| US-20200384085-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2020-12-10 | — | — | US | disclosed |
| WO-2001085013-A2 | INFRARED THERMOGRAPHY AND METHODS OF USE | NITROMED, INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6306841-B1 | NITROVASODILATOR SELECTED FROM SODIUM NITROPRUSSIDE, DIAZENIUM DIOLATE MOLSIDOMINE, LINSIDOMINE CHLORHYDRATE, S-NITROSOTHIOLS, ORGANIC NITRATES, PHARMACOLOGICALLY ACCEPTABLE SALTS, | ASIVI, LLC | 2001-10-23 | — | — | US | disclosed |
| US-6294550-B1 | ADMINISTERING A VASOACTIVE AGENT FROM ERGOTAMINE DRUG | ASIVI, LLC | 2001-09-25 | — | — | US | disclosed |
| US-6266560-B1 | Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction | GENETRONICS, INC. | 2001-07-24 | — | — | US | disclosed |
| WO-2001041807-A2 | TRANSMUCOSAL COMPOSITION CONTAINING A PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | VIVUS, INC. (US) | 2001-06-14 | — | — | WO | disclosed |
| US-6156753-A | Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction | VIVUS, INC. (US) | 2000-12-05 | — | — | US | disclosed |
| US-6127363-A | FOR TRANSURETHRAL OR TRANSDERMAL ADMINISTRATION OR INTRACAVERNOSAL INJECTION, KITS | VIVUS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| WO-1999065563-A1 | ELECTRICALLY ASSISTED TRANSDERMAL METHOD AND APPARATUS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | GENETRONICS, INC. (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5877216-A | ADMINISTERING VASODILATING AGENT CONTAINING PROSTAGLANDINS | VIVUS, INCORPORATED (US) | 1999-03-02 | — | — | US | disclosed |